TriSalus Life Sciences, Inc. Q4 Loss Decreases, But Misses Estimates

TriSalus Life Sciences, Inc. (TLSI) released Loss for fourth quarter that decreased from the same period last year but missed the Street estimates.

The company's bottom line came in at -$10.89 million, or -$0.40 per share. This compares with -$36.44 million, or -$1.57 per share, last year.

Analysts on average had expected the company to earn -$0.35 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period rose 44.4% to $8.26 million from $5.72 million last year.

TriSalus Life Sciences, Inc. earnings at a glance (GAAP) :

-Earnings: -$10.89 Mln. vs. -$36.44 Mln. last year.
-EPS: -$0.40 vs. -$1.57 last year.
-Revenue: $8.26 Mln vs. $5.72 Mln last year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com